Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1250 A novel in vivo PBMC humanized mouse platform for long-term analysis of efficacy and toxicity of T cell-based immunotherapy drugs
Compose a Response to This Article
Other responses
No responses have been published for this article.